Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Shareholders OK Merck KGaA Acquisition

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore today said that its shareholders have voted in favor of the firm's acquisition by Germany's Merck KGaA.

The Billerica, Mass.-based research products firm said that shareholders representing around 79 percent of its shares voted, with 98 percent voting in favor of the deal.

The firm agreed to the $7.2 billion deal earlier this year, with Merck offering $107 per share in cash for all outstanding shares of Millipore. The deal was announced several days after reports had surfaced that thermo Fisher Scientific had made a $6 billion bid for Millipore.

Completion of the deal still requires clearance from US antitrust authorities. The partners hope to complete the acquisition early in the third quarter of 2010.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.